Cardiometabolic Syndrome
55
17
19
21
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.8%
1 terminated out of 55 trials
95.5%
+8.9% vs benchmark
2%
1 trials in Phase 3/4
10%
2 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (55)
RE-inventing Strategies for Healthy Ageing; Recommendations and Tools
Effects of Berberine on Cardiometabolic Outcomes
Spinal Cord Injury Model Systems (SCIMS) - Education Module
Establishing Clinical Utility Evidence for Chronic Disease Management Testing
Effects of Quercetin on Cardiometabolic Outcomes
The Role of Ectopic Fat and Heart Attack Risk in HIV
The Mom and Infant Outcomes (MOMI) Study
FEAST Perinatal Support Program Intervention
Effect of Interrupting Sedentary Time With Different Frequencies of Physical Activity on Cardiometabolic Risk Factors
Time Restricted Eating (TRE) and High-Intensity Interval Training (HIIT) to Improve Health in Patients With Metabolic Syndrome (METS)
PDE3B in Metabolic Regulation
Time-Restricted Eating, Exercise and Cardiometabolic Health in Obesity
Peau o le Vasa: Analysis of the Efficacy and Feasibility of the PILI Lifestyle Program (PLP) + Social Determinants of Health (SDOH) Intervention and Adaptation of SDOH Measures Pilot Study
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
Shift-and-persist and Cardiometabolic Markers Among Women in Puerto Rico
A Study Comparing the Health Effects of Two Diets Following UK Dietary Guidance in People Living With Overweight or Obesity
Telenutrition for Individuals With SCI
Impact of Yo-Yo Sleep on Cardiometabolic Health
Weekly Family Food Packages: Food is Medicine